IL148196A0 - Heterocyclic compounds and pharmaceutical compositions containing the same - Google Patents

Heterocyclic compounds and pharmaceutical compositions containing the same

Info

Publication number
IL148196A0
IL148196A0 IL14819600A IL14819600A IL148196A0 IL 148196 A0 IL148196 A0 IL 148196A0 IL 14819600 A IL14819600 A IL 14819600A IL 14819600 A IL14819600 A IL 14819600A IL 148196 A0 IL148196 A0 IL 148196A0
Authority
IL
Israel
Prior art keywords
present
prevention
treatment
bacterial infections
compound described
Prior art date
Application number
IL14819600A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL148196A0 publication Critical patent/IL148196A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL14819600A 1999-08-20 2000-08-18 Heterocyclic compounds and pharmaceutical compositions containing the same IL148196A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23393499 1999-08-20
PCT/JP2000/005538 WO2001014399A1 (fr) 1999-08-20 2000-08-18 Nouveaux derives a-500359

Publications (1)

Publication Number Publication Date
IL148196A0 true IL148196A0 (en) 2002-09-12

Family

ID=16962911

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14819600A IL148196A0 (en) 1999-08-20 2000-08-18 Heterocyclic compounds and pharmaceutical compositions containing the same
IL148196A IL148196A (en) 1999-08-20 2002-02-17 History of capuramycin and the pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148196A IL148196A (en) 1999-08-20 2002-02-17 History of capuramycin and the pharmaceutical preparations containing them

Country Status (25)

Country Link
US (1) US7157442B2 (ru)
EP (1) EP1209166B1 (ru)
KR (1) KR100787849B1 (ru)
CN (1) CN1176936C (ru)
AT (1) ATE263183T1 (ru)
AU (1) AU763492B2 (ru)
BR (1) BR0013435A (ru)
CA (1) CA2382654C (ru)
CZ (1) CZ2002682A3 (ru)
DE (1) DE60009517T2 (ru)
DK (1) DK1209166T3 (ru)
ES (1) ES2216933T3 (ru)
HK (1) HK1044951A1 (ru)
HU (1) HUP0204217A3 (ru)
IL (2) IL148196A0 (ru)
MX (1) MXPA02001817A (ru)
NO (1) NO323556B1 (ru)
NZ (1) NZ517315A (ru)
PL (1) PL353494A1 (ru)
PT (1) PT1209166E (ru)
RU (1) RU2227799C2 (ru)
TR (1) TR200200485T2 (ru)
TW (1) TWI245047B (ru)
WO (1) WO2001014399A1 (ru)
ZA (1) ZA200201409B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID27955A (id) * 1998-07-09 2001-05-03 Sankyo Co Senyawa-senyawa antimikroba yang baru
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
WO2005034857A2 (en) * 2003-09-05 2005-04-21 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues
KR101104505B1 (ko) * 2010-01-30 2012-01-12 김근섭 호스 연결용 원클릭 피팅
WO2015027137A1 (en) * 2013-08-23 2015-02-26 University Of Tennessee Research Foundation Improved synthesis of capuramycin and its analogues
WO2022006231A1 (en) * 2020-06-30 2022-01-06 University Of Tennessee Research Foundation Dpagt1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
JP4428762B2 (ja) 1998-07-09 2010-03-10 セケラ インコーポレイテッド 抗生物質ａ−５００３５９及び誘導体
ID27955A (id) 1998-07-09 2001-05-03 Sankyo Co Senyawa-senyawa antimikroba yang baru
JP4531167B2 (ja) 1998-09-24 2010-08-25 セケラ インコーポレイテッド 新規抗細菌化合物
JP4960548B2 (ja) * 2000-01-07 2012-06-27 セケラ インコーポレイテッド 新規抗細菌化合物の用途
JP5022539B2 (ja) 2000-01-07 2012-09-12 セケラ インコーポレイテッド 抗生物質ａ−５００３５９及び誘導体を含有する抗菌剤

Also Published As

Publication number Publication date
CA2382654A1 (en) 2001-03-01
NZ517315A (en) 2004-02-27
AU763492B2 (en) 2003-07-24
KR100787849B1 (ko) 2007-12-27
DE60009517D1 (de) 2004-05-06
US20030171330A1 (en) 2003-09-11
US7157442B2 (en) 2007-01-02
CN1176936C (zh) 2004-11-24
HUP0204217A2 (en) 2003-03-28
CZ2002682A3 (cs) 2002-06-12
HK1044951A1 (en) 2002-11-08
CA2382654C (en) 2009-01-13
NO323556B1 (no) 2007-06-11
ES2216933T3 (es) 2004-11-01
ZA200201409B (en) 2003-07-30
TR200200485T2 (tr) 2002-06-21
IL148196A (en) 2008-06-05
EP1209166A1 (en) 2002-05-29
KR20020092901A (ko) 2002-12-12
PL353494A1 (en) 2003-11-17
CN1382152A (zh) 2002-11-27
EP1209166A4 (en) 2002-10-09
EP1209166B1 (en) 2004-03-31
DK1209166T3 (da) 2004-07-26
DE60009517T2 (de) 2005-01-13
NO20020804D0 (no) 2002-02-19
WO2001014399A1 (fr) 2001-03-01
AU6595500A (en) 2001-03-19
NO20020804L (no) 2002-04-19
ATE263183T1 (de) 2004-04-15
PT1209166E (pt) 2004-06-30
RU2227799C2 (ru) 2004-04-27
TWI245047B (en) 2005-12-11
HUP0204217A3 (en) 2005-11-28
BR0013435A (pt) 2002-07-16
MXPA02001817A (es) 2002-08-12

Similar Documents

Publication Publication Date Title
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
CA2103590A1 (en) Benzamide derivative
PT992509E (pt) Novos derivados macrolidos
IL148196A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
DE60123827D1 (en) 1-methylcarbapenemderivate
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
IL103826A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HK1045522A1 (en) Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
WO2000078793A3 (en) Antimicrobial agents
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
DE69424677T2 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted